Emily P. Slater
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 2%
- Cancer Research top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Co-authors
- Miguel BeatoJohn D. BaxterDetlef K. BartschGeorges ChalepakisMichael KarinPamela L. MellonMichael SchauerVolker Fendrich
- Topics
- Pancreatic and Hepatic Oncology Research (23 papers)Neuroendocrine Tumor Research Advances (19 papers)Estrogen and related hormone effects (16 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Emily P. Slater
90 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 1.4k
- Oncology 1.0k
- Genetics 1.0k
- Cancer Research 598
- Endocrinology, Diabetes and Metabolism 543
Countries citing papers authored by Emily P. Slater
This map shows the geographic impact of Emily P. Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily P. Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily P. Slater more than expected).
Fields of papers citing papers by Emily P. Slater
This network shows the impact of papers produced by Emily P. Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily P. Slater. The network helps show where Emily P. Slater may publish in the future.
Co-authorship network of co-authors of Emily P. Slater
This figure shows the co-authorship network connecting the top 25 collaborators of Emily P. Slater. A scholar is included among the top collaborators of Emily P. Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily P. Slater. Emily P. Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 29 | |
| 4 | 29 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 28 | |
| 10 | 37 | |
| 11 | 20 | |
| 12 | 9 | |
| 13 | 60 | |
| 14 | 40 | |
| 15 | 27 | |
| 16 | 37 | |
| 17 | 28 | |
| 18 | 8 | |
| 19 | 2 | |
| 20 | 187 |
About Emily P. Slater
Emily P. Slater is a scholar working on Oncology, Cancer Research and Neurology, having authored 91 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (23 papers), Neuroendocrine Tumor Research Advances (19 papers) and Estrogen and related hormone effects (16 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (1.0k citations) and Genetics (1.0k citations). Emily P. Slater has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Miguel Beato, John D. Baxter, Detlef K. Bartsch, Georges Chalepakis, Michael Karin, Pamela L. Mellon, Michael Schauer, Volker Fendrich, Ulrike Fuhrmann and Karl‐Heinrich Fritzemeier. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.